Liu Tian
Clinical trials sponsored by Liu Tian, explained in plain language.
-
New hope for rare gut disease? small study tests biologic drug
Disease control CompletedThis study tested a drug called ustekinumab in 8 people with a rare, severe form of Behçet's syndrome affecting the gut, along with a blood disorder called myelodysplastic syndrome. The goal was to see if the drug could control gut symptoms and reduce disease activity over 24 wee…
Phase: PHASE2 • Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for rare artery disease? small trial tests upadacitinib
Disease control CompletedThis completed study tested the drug upadacitinib in 12 people with refractory Takayasu arteritis, a rare autoimmune disease that inflames the body's largest artery. The goal was to see if the drug could help patients who haven't responded to standard treatments achieve remission…
Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill shows promise for rare inflammatory disease
Disease control CompletedThis study tested the drug upadacitinib in 27 adults with Behcet's syndrome that did not improve with standard treatments. The goal was to see if the drug could control symptoms like skin, eye, and blood vessel problems. Results showed that many participants had their symptoms re…
Phase: PHASE2 • Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC